Daniel Bensen, Chief Operating Officer at Tyra Biosciences, Inc. (TYRA), sold 14,215 shares at $20.04 ($285K) on 2024-03-01, disclosed to the SEC on 2024-03-05.
Scheduled sale ($285k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.04 | 2,900 | $58K | 20.4% |
| 2 | $20.08 | 5,063 | $102K | 35.6% |
| 3 | $20.08 | 5,063 | $102K | 35.6% |
| 4 | $20.02 | 1,189 | $24K | 8.3% |
| Total | $20.07 avg | 14,215 | $285K | 100% |
| Filing → |
| TYRA | SELL | 2025-12-16 | $181K | — | Filing → |
| TYRA | SELL | 2025-11-19 | $4.1M | — | Filing → |
| TYRA | SELL | 2025-11-17 | $4.2M | — | Filing → |